Loading...
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
IGC’s FA Score shows that 0 FA rating(s) are green whileNNBR’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
IGC’s TA Score shows that 4 TA indicator(s) are bullish while NNBR’s TA Score has 4 bullish TA indicator(s).
IGC (@Biotechnology) experienced а +20.93% price change this week, while NNBR (@Metal Fabrication) price change was -10.40% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +5.27%. For the same industry, the average monthly price growth was -0.50%, and the average quarterly price growth was +1243.13%.
The average weekly price growth across all stocks in the @Metal Fabrication industry was +1.03%. For the same industry, the average monthly price growth was +2.11%, and the average quarterly price growth was +108.85%.
IGC is expected to report earnings on Aug 07, 2024.
NNBR is expected to report earnings on Aug 01, 2024.
Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
@Metal Fabrication (+1.03% weekly)The industry is involved in value-added processes including creation of metal structures like machines and parts by cutting, bending and assembling, using various raw materials. A fabrication shop often bids on a project/job, and then builds the product if awarded the contract. Robotics and automation are making their way into the industry apparently to fill in skills gap[s19] . RBC Bearings Incorporated, Timken Company and Valmont Industries, Inc. are some of the largest metal fabrication companies in the U.S.
IGC | NNBR | IGC / NNBR | |
Capitalization | 34.7M | 233M | 15% |
EBITDA | N/A | 13.5M | - |
Gain YTD | 85.648 | -16.000 | -535% |
P/E Ratio | N/A | N/A | - |
Revenue | N/A | 489M | - |
Total Cash | N/A | 21.9M | - |
Total Debt | N/A | 206M | - |
IGC | NNBR | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 8 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 48 Fair valued | 91 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 98 | 97 | |
PRICE GROWTH RATING 1..100 | 36 | 39 | |
P/E GROWTH RATING 1..100 | 100 | 94 | |
SEASONALITY SCORE 1..100 | n/a | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
IGC's Valuation (48) in the Biotechnology industry is somewhat better than the same rating for NNBR (91) in the Metal Fabrication industry. This means that IGC’s stock grew somewhat faster than NNBR’s over the last 12 months.
IGC's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as NNBR (100) in the Metal Fabrication industry. This means that IGC’s stock grew similarly to NNBR’s over the last 12 months.
NNBR's SMR Rating (97) in the Metal Fabrication industry is in the same range as IGC (98) in the Biotechnology industry. This means that NNBR’s stock grew similarly to IGC’s over the last 12 months.
IGC's Price Growth Rating (36) in the Biotechnology industry is in the same range as NNBR (39) in the Metal Fabrication industry. This means that IGC’s stock grew similarly to NNBR’s over the last 12 months.
NNBR's P/E Growth Rating (94) in the Metal Fabrication industry is in the same range as IGC (100) in the Biotechnology industry. This means that NNBR’s stock grew similarly to IGC’s over the last 12 months.
IGC | NNBR | |
---|---|---|
RSI ODDS (%) | 2 days ago89% | 2 days ago84% |
Stochastic ODDS (%) | 2 days ago87% | 2 days ago79% |
Momentum ODDS (%) | 2 days ago80% | 2 days ago84% |
MACD ODDS (%) | 2 days ago90% | 5 days ago90% |
TrendWeek ODDS (%) | 2 days ago83% | 2 days ago83% |
TrendMonth ODDS (%) | 2 days ago84% | 2 days ago82% |
Advances ODDS (%) | 4 days ago82% | 16 days ago82% |
Declines ODDS (%) | 9 days ago83% | 2 days ago89% |
BollingerBands ODDS (%) | 3 days ago90% | 2 days ago79% |
Aroon ODDS (%) | N/A | 2 days ago82% |
A.I.dvisor tells us that NNBR and MATW have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NNBR and MATW's prices will move in lockstep.
Ticker / NAME | Correlation To NNBR | 1D Price Change % | ||
---|---|---|---|---|
NNBR | 100% | -4.95% | ||
MATW - NNBR | 27% Poorly correlated | +1.54% | ||
ESAB - NNBR | 21% Poorly correlated | +2.22% | ||
CODI - NNBR | 20% Poorly correlated | -5.49% | ||
TRC - NNBR | 20% Poorly correlated | +0.18% | ||
IEP - NNBR | 19% Poorly correlated | -0.34% | ||
More |